Orit Bar‐Am - Concepedia

Author

Orit Bar‐Am

Technion – Israel Institute of Technology

Also Known As

O Bar-Am, O Bar‐Am, O. Bar-Am, ORIT BAR‐AM, Orit Bar-Am, Orit Bar‐Am

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Technion – Israel Institute of Technology Foundation Center Rappaport Family Institute for Research in the Medical Sciences Family Research Institute Hebrew University of Jerusalem

About

Orit Bar‐Am is an author at Technion – Israel Institute of Technology specializing in medicine, pharmacology, and neuroprotection.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.6K
2	Social Sciences	6	7	585
3	Biochemistry	6	6	577
4	Natural Sciences	2	2	379
5	Engineering	1	1	22

Orit Bar‐Am

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer’s, Parkinson’s, and other neurodegenerative diseases Hailin Zheng, Lev Weiner, Orit Bar‐Am, Bioorganic & Medicinal Chemistry Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryOther Neurodegenerative DiseasesPotential Agents	2004	276
Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: <i>in vitro</i> studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition Hailin Zheng, Shunit Gal, Lev Weiner, Journal of Neurochemistry	2005	213
Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members Orly Weinreb, Orit Bar‐Am, Tamar Amit, The FASEB Journal ApoptosisCell DeathSocial SciencesOxidative StressNeuroinflammation	2004	186
Regulation of Bcl‐2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine Orit Bar‐Am, Orly Weinreb, Tamar Amit, The FASEB Journal App ProcessingApoptosisNeurotransmitterCell DeathNeurotransmission	2005	164
Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease<sup>1</sup> Yael Avramovich‐Tirosh, Tamar Amit, Orit Bar‐Am, Journal of Neurochemistry Neurodegenerative DiseasesAlzheimer's DiseaseDrug CandidatesMedicineExperimental Neuropathology	2006	131
The importance of propargylamine moiety in the anti‐ Parkinson drug rasagiline and its derivatives for MAPK‐ dependent amyloid precursor protein processing Merav Yogev‐Falach, Tamar Amit, Orit Bar‐Am, The FASEB Journal	2003	117
Regulation of protein kinase C by the anti‐Parkinson drug, MAO‐B inhibitor, rasagiline and its derivatives, <i>in vivo</i> Orit Bar‐Am, Merav Yogev‐Falach, Tamar Amit, Journal of Neurochemistry	2004	108
The involvement of mitogen‐activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline Merav Yogev‐Falach, Tamar Amit, Orit Bar‐Am, The FASEB Journal Amyloid Precursor ProteinMedicinal ChemistryMethyl CarbamateAlzheimer's DiseaseDegenerative Pathology	2002	103
Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging Orit Bar‐Am, Tamar Amit, Lana Kupershmidt, Neurobiology of Aging Neurorestorative ActivitiesMedicineAnimal ModelsNeuropharmacologyNeurochemical Biomarkers	2014	85
A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo‐APP translation and processing Merav Yogev‐Falach, Orit Bar‐Am, Tamar Amit, The FASEB Journal Amyloid Precursor ProteinHolo‐app TranslationSocial SciencesTranslational PharmacologyNeuroprotective Drug	2006	85

Page 1